Michael Autenrieth

1.4k total citations
45 papers, 557 citations indexed

About

Michael Autenrieth is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michael Autenrieth has authored 45 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Michael Autenrieth's work include Renal cell carcinoma treatment (12 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Urinary and Genital Oncology Studies (12 papers). Michael Autenrieth is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Urinary and Genital Oncology Studies (12 papers). Michael Autenrieth collaborates with scholars based in Germany, United States and Switzerland. Michael Autenrieth's co-authors include Jürgen E. Gschwend, Hubert Kübler, Margitta Retz, Tobias Maurer, Thomas Horn, Matthias Heck, Mark Thalgott, Frank Bruchertseifer, Christof Seidl and Aliyah Morgenstern and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and European Urology.

In The Last Decade

Michael Autenrieth

42 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Autenrieth Germany 14 259 193 157 115 68 45 557
Séverine Banek Germany 15 290 1.1× 249 1.3× 99 0.6× 162 1.4× 128 1.9× 65 592
Martijn B. Busstra Netherlands 13 316 1.2× 103 0.5× 126 0.8× 124 1.1× 78 1.1× 32 493
Christopher Darr Germany 11 272 1.1× 135 0.7× 110 0.7× 131 1.1× 76 1.1× 58 501
Sabina Sevcenco Austria 13 297 1.1× 126 0.7× 187 1.2× 63 0.5× 147 2.2× 39 512
B. Mayer Grob United States 11 497 1.9× 128 0.7× 300 1.9× 176 1.5× 157 2.3× 32 795
Lucas Nogueira United States 15 572 2.2× 244 1.3× 107 0.7× 85 0.7× 225 3.3× 46 773
Christopher Pieczonka United States 12 433 1.7× 142 0.7× 111 0.7× 136 1.2× 56 0.8× 69 679
John B. Eifler United States 9 400 1.5× 169 0.9× 73 0.5× 45 0.4× 47 0.7× 18 536
Handoo Rhee Australia 12 555 2.1× 62 0.3× 244 1.6× 143 1.2× 135 2.0× 40 700
Michael Dattoli United States 13 432 1.7× 120 0.6× 47 0.3× 42 0.4× 52 0.8× 27 638

Countries citing papers authored by Michael Autenrieth

Since Specialization
Citations

This map shows the geographic impact of Michael Autenrieth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Autenrieth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Autenrieth more than expected).

Fields of papers citing papers by Michael Autenrieth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Autenrieth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Autenrieth. The network helps show where Michael Autenrieth may publish in the future.

Co-authorship network of co-authors of Michael Autenrieth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Autenrieth. A scholar is included among the top collaborators of Michael Autenrieth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Autenrieth. Michael Autenrieth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erlmeier, Franziska, Stefanie Zschäbitz, Marie Mikuteit, et al.. (2023). The role of claudin-6 in chromophobe renal cell carcinoma.. PubMed. 38(4). 403–407. 2 indexed citations
2.
Mikuteit, Marie, Stefanie Zschäbitz, Michael Autenrieth, et al.. (2022). Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma. Oncology. 100(10). 536–541.
3.
Weirich, Gregor, Tobias Maurer, Stefan Wagenpfeil, et al.. (2022). Ultrasound-based “CEUS-Bosniak”classification for cystic renal lesions: an 8-year clinical experience. World Journal of Urology. 41(3). 679–685. 17 indexed citations
4.
Mikuteit, Marie, Sandra Steffens, Stefanie Zschäbitz, et al.. (2022). Trophoblast Cell Surface Antigen 2 (Trop2) in Chromophobe Renal Cell Carcinoma. Oncology. 100(6). 331–336. 2 indexed citations
5.
Lunger, Lukas, Margitta Retz, Gregor Weirich, et al.. (2020). KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy. Prostate Cancer and Prostatic Diseases. 24(2). 362–369. 8 indexed citations
6.
Heck, Matthias, Florestan Koll, Margitta Retz, et al.. (2020). Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection. Urologic Oncology Seminars and Original Investigations. 38(7). 639.e11–639.e19. 4 indexed citations
7.
Stock, Konrad, Julia Slotta‐Huspenina, Hubert Kübler, & Michael Autenrieth. (2019). Innovative Ultraschalldiagnostik bei Nierentumoren. Der Urologe. 58(12). 1418–1428. 8 indexed citations
8.
Heck, Matthias, Margitta Retz, Gregor Weirich, et al.. (2018). Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection. Clinical Cancer Research. 24(10). 2342–2349. 10 indexed citations
9.
Autenrieth, Michael, Thomas Horn, Karine Nguyen, et al.. (2016). Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-Versagen. Der Urologe. 56(1). 40–43. 8 indexed citations
10.
Fazel, Julia, Christof Seidl, Benedikt Feuerecker, et al.. (2015). Fractionated intravesical radioimmunotherapy with213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma. Cancer Biology & Therapy. 16(10). 1526–1534. 24 indexed citations
11.
Horn, Thomas, Sebastian C. Schmid, Matthias Heck, et al.. (2015). Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy. Urologia Internationalis. 96(1). 51–56. 38 indexed citations
12.
Erlmeier, Franziska, Annette Feuchtinger, Martina Rudelius, et al.. (2015). Supremacy of modern morphometry in typing renal oncocytoma and malignant look-alikes. Histochemistry and Cell Biology. 144(2). 147–156. 11 indexed citations
13.
Schmid, Sebastian, Pascal O. Berberat, Jürgen E. Gschwend, & Michael Autenrieth. (2014). Praktische Studentenausbildung in der Urologie. Der Urologe. 53(4). 537–541. 4 indexed citations
14.
Horn, Thomas, Sebastian C. Schmid, Anna Katharina Seitz, et al.. (2014). Clinical prognosticators of survival in patients with urothelial carcinoma of the bladder and lymph node metastases after cystectomy with curative intent. World Journal of Urology. 33(6). 813–819. 6 indexed citations
15.
16.
Tauber, Robert, Sebastian C. Schmid, Thomas Horn, et al.. (2012). Inguinal lymph node dissection: Epidermal vacuum therapy for prevention of wound complications. Journal of Plastic Reconstructive & Aesthetic Surgery. 66(3). 390–396. 48 indexed citations
17.
Fazel, Julia, Christof Seidl, Michael Autenrieth, et al.. (2010). Fractionated locoregional alpha-radioimmunotherapy of bladder cancer in a nude mouse model. mediaTUM (Technical University of Munich). 1 indexed citations
18.
Seidl, Christof, Michael Autenrieth, Dieter Saur, et al.. (2009). Intravesical α-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice. Journal of Nuclear Medicine. 50(10). 1700–1708. 57 indexed citations
19.
Autenrieth, Michael, et al.. (2008). Muskelinvasives Urothelkarzinom der Harnblase. Der Urologe. 47(9). 1157–1161. 8 indexed citations
20.
Autenrieth, Michael, et al.. (2006). Systemische Therapie des metastasierten Nierenzellkarzinoms. Der Urologe. 45(5). 594–599. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Séverine Banek Breakdown of academic impact, for papers by Martijn B. Busstra Breakdown of academic impact, for papers by Christopher Darr Breakdown of academic impact, for papers by Sabina Sevcenco Breakdown of academic impact, for papers by B. Mayer Grob Breakdown of academic impact, for papers by Lucas Nogueira Breakdown of academic impact, for papers by Christopher Pieczonka Breakdown of academic impact, for papers by John B. Eifler Breakdown of academic impact, for papers by Handoo Rhee Breakdown of academic impact, for papers by Michael Dattoli
Rankless by CCL
2026